Compare PCVX & CCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCVX | CCK |
|---|---|---|
| Founded | 2013 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 11.5B |
| IPO Year | 2020 | 2003 |
| Metric | PCVX | CCK |
|---|---|---|
| Price | $58.12 | $102.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 16 |
| Target Price | $98.33 | ★ $122.75 |
| AVG Volume (30 Days) | ★ 1.1M | 835.2K |
| Earning Date | 05-06-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 1.01% |
| EPS Growth | N/A | ★ 79.72 |
| EPS | N/A | ★ 6.38 |
| Revenue | N/A | ★ $11,665,000,000.00 |
| Revenue This Year | N/A | $4.97 |
| Revenue Next Year | N/A | $2.39 |
| P/E Ratio | ★ N/A | $16.12 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.09 | $75.98 |
| 52 Week High | $65.00 | $116.62 |
| Indicator | PCVX | CCK |
|---|---|---|
| Relative Strength Index (RSI) | 56.87 | 46.53 |
| Support Level | $42.30 | $102.15 |
| Resistance Level | $58.95 | $102.91 |
| Average True Range (ATR) | 2.13 | 2.54 |
| MACD | 0.28 | 0.19 |
| Stochastic Oscillator | 81.15 | 57.44 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
Crown Holdings Inc is a producer of metal packaging. The company manufactures beverage cans, metal food cans, and closures, as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.